Search

Displaying results 11 - 20 of 23 in total
  1. Indication

    Advanced, primary Endometrial Cancer

    go.drugbank.com/conditions/DBCOND0168675
    Drugs: Dostarlimab · Durvalumab
  2. Indication

    Recurrent Endometrial Cancer

    go.drugbank.com/conditions/DBCOND0054384
    Drugs: Dostarlimab · Durvalumab
  3. Indication

    Advanced Mismatch Repair-deficient (dMMR) Endometrial Cancer

    go.drugbank.com/conditions/DBCOND0138846
    Drugs: Dostarlimab · Durvalumab
  4. Indication

    Recurrent Mismatch Repair-deficient (dMMR) Endometrial Cancer

    go.drugbank.com/conditions/DBCOND0138845
    Drugs: Dostarlimab · Durvalumab
  5. Indication

    Advanced Hepatocellular Carcinoma (HCC)

    go.drugbank.com/conditions/DBCOND0046987
    Drugs: Durvalumab · Ipilimumab · Nivolumab
  6. Indication

    Metastatic Biliary Tract Cancer

    go.drugbank.com/conditions/DBCOND0046438
    Drugs: Durvalumab · Pembrolizumab · Zanidatamab
  7. Indication

    Locally advanced Urothelial Carcinoma

    go.drugbank.com/conditions/DBCOND0089492
    Drugs: Avelumab · Durvalumab · Nivolumab · Pembrolizumab
  8. Indication

    Muscle-invasive Bladder Cancer

    go.drugbank.com/conditions/DBCOND0042339
    Drugs: Atezolizumab · Durvalumab · Enfortumab vedotin · Pembrolizumab
  9. Indication

    Resectable Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0068626
    Drugs: Durvalumab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab
  10. Indication

    Extensive-stage Small Cell Lung Cancer (ES-SCLC)

    go.drugbank.com/conditions/DBCOND0168067
    Drugs: Atezolizumab · Durvalumab · Lurbinectedin · Serplulimab · Tarlatamab · Tislelizumab